Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity
- jeanfrancoismaison
- Jun 4
- 1 min read
top of page
Search
Recent Posts
See Allhttps://pubmed.ncbi.nlm.nih.gov/40467521/
https://pubmed.ncbi.nlm.nih.gov/40450523/
https://pubmed.ncbi.nlm.nih.gov/40464483/
bottom of page
Comments